Patients' Perspectives on Adverse Drug Reaction Reporting in a Developing Country: A Case Study from Ghana.

Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol (2007) 2.97

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis. Drug Saf (2010) 2.77

Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys. Health Technol Assess (2011) 2.71

Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf (2014) 2.29

Experiences with adverse drug reaction reporting by patients: an 11-country survey. Drug Saf (2012) 1.79

Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance. Drug Saf (2011) 1.78

Consumer adverse drug reaction reporting: a new step in pharmacovigilance? Drug Saf (2003) 1.50

Behavioural considerations for hand hygiene practices: the basic building blocks. J Hosp Infect (2006) 1.43

Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf (2007) 1.42

The expert patient: a new approach to chronic disease management for the twenty-first century. Clin Med (2002) 1.40

Factors affecting the development of adverse drug reactions (Review article). Saudi Pharm J (2013) 1.17

Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol (2011) 1.16

Patient safety culture: factors that influence clinician involvement in patient safety behaviours. Qual Saf Health Care (2010) 1.14

Effect of consumer reporting on signal detection: using disproportionality analysis. Expert Opin Drug Saf (2007) 1.11

How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme. Drug Saf (2013) 1.10

The importance of direct patient reporting of suspected adverse drug reactions: a patient perspective. Br J Clin Pharmacol (2011) 1.10

The proportion of patient reports of suspected ADRs to signal detection in the Netherlands: case-control study. Pharmacoepidemiol Drug Saf (2010) 1.09

Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol (2010) 1.07

Predictors of safer sex intentions and protected sex among heterosexual HIV-negative methamphetamine users: an expanded model of the Theory of Planned Behavior. AIDS Care (2009) 1.03

What can consumer adverse drug reaction reporting add to existing health professional-based systems? Focus on the developing world. Drug Saf (2003) 0.99

Adverse drug reaction reports of patients and healthcare professionals-differences in reported information. Pharmacoepidemiol Drug Saf (2014) 0.93

Survey to assess public awareness of patient reporting of adverse drug reactions in Great Britain. J Clin Pharm Ther (2011) 0.92

Low awareness of adverse drug reaction reporting systems: a consumer survey. Med J Aust (2013) 0.88

Examination of pharmacists' intention to report serious adverse drug events (ADEs) to the FDA using the theory of planned behavior. Res Social Adm Pharm (2010) 0.87

Adverse drug reactions reporting : Knowledge and opinion of general public in Penang, Malaysia. J Pharm Bioallied Sci (2013) 0.83

Patient Reporting of Adverse Drug Reactions: An International Survey of National Competent Authorities' Views and Needs. Drug Saf (2016) 0.81

New rules will allow EU patients to report drug concerns directly. BMJ (2010) 0.80

Adverse drug reaction reporting by doctors in a developing country: a case study from Ghana. Ghana Med J (2014) 0.79

Patient-Reported Safety Information: A Renaissance of Pharmacovigilance? Drug Saf (2016) 0.79

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase(®). Drug Saf (2016) 0.78

Patients' beliefs about adherence to oral antidiabetic treatment: a qualitative study. Patient Prefer Adherence (2015) 0.78

Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting. Eur J Clin Pharmacol (2015) 0.77

Testing an explanatory model of nurses' intention to report adverse drug reactions in hospital settings. J Nurs Manag (2017) 0.77

Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care. EMBO Rep (2016) 0.75